Mazor X is Medtronic's flagship spine robot, and its Stealth edition includes enabling technologies including navigation, 3-D imaging, robotics and powered surg ...
Winkels said that the software glitch only affected cranial and ENT (ears, nose and throat) procedures. Medtronic Navigation Inc. issued an "urgent medical device correction letter" about ...
Medtronic Plc is a medical technology company ... The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions.
Medtronic (MDT) reported $7.92 billion in revenue for the quarter ended July 2024, representing a year-over-year increase of 2.8%. EPS of $1.23 for the same period compares to $1.20 a year ago.
Medtronic faced challenges, including poor focus, lack of innovation, and COVID-19 impact, leading to share price stagnation since 2018. Despite recent improvements in performance, Medtronic ...
developed technology and partnered with Medtronic to develop the first StealthStation™ machine. This revolutionized the field, offering neurosurgeons and their patients stereotactic navigation for ...
Medtronic delivered a strong first-quarter earnings report. The company benefits from continued market adoption of several new product launches over the past year. The stock looks attractive ...
Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 13% over the last month. We, however wanted to have a closer look at its key financial indicators as ...
WANG GANG / Feature China / Future Publishing via Getty Images Medtronic beat first-quarter earnings and revenue estimates on strong sales of its medical devices. Sales were higher at the company ...
Aug 20 (Reuters) - Medtronic (MDT.N), opens new tab slightly lifted the lower end of its annual profit forecast on Tuesday, banking on sustained demand for its medical devices and growth from its ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...